Incentive effects of government subsidy on technological innovation: Evidence from pharmaceutical industry

Tingting Yang and Botong Xu

Finance Research Letters, 2023, vol. 55, issue PA

Abstract: It is important to motivate pharmaceutical companies in technological innovation. We study the incentive effects of three types of government subsidies, including R&D subsidies, tax incentives, and non-R&D subsidies, on pharmaceutical companies’ innovation. Results show that: 1) R&D subsidies have a significant positive effect on the innovation performance, while tax incentives have no positive impact on this. 2) Tax incentives positively (negatively) affect the innovation performance of state-owned (private) companies. 3) R&D subsidies ease the financing constraints and encourage companies to increase R&D investment, thereby enhancing the innovation. Our findings have implications on inspiring innovation in the pharmaceutical industry.

Keywords: R&D subsidies; Tax incentives; Innovation performance; Pharmaceutical industry (search for similar items in EconPapers)
Date: 2023
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (3)

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S1544612323003008
Full text for ScienceDirect subscribers only

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:finlet:v:55:y:2023:i:pa:s1544612323003008

DOI: 10.1016/j.frl.2023.103928

Access Statistics for this article

Finance Research Letters is currently edited by R. Gençay

More articles in Finance Research Letters from Elsevier
Bibliographic data for series maintained by Catherine Liu ().